Minimally invasive surgery in cervical cancer

Area of Science:

• Gynecologic Oncology
• Surgical Oncology
• Minimally Invasive Surgery

Background:

• Minimally invasive surgery (MIS) has largely replaced open surgery in gynecology.
• The Laparoscopic Approach to Cervical Cancer (LACC) trial raised concerns about MIS for early-stage cervical cancer.
• Evidence regarding MIS in cervical cancer requires critical evaluation.

Purpose of the Study:

• To review current evidence on MIS for cervical cancer.
• To analyze factors influencing MIS outcomes, including tumor volume and recurrence risk.
• To assess MIS impact on locally advanced cervical cancer.

Main Methods:

• Literature review and evidence synthesis.
• Focus on tumor volume, adverse outcomes, recurrence reduction strategies, and advanced disease.
• Evaluation of data from recent clinical trials and observational studies.

Main Results:

• The LACC trial indicated potential disadvantages of MIS in early-stage cervical cancer.
• Factors contributing to worse outcomes with MIS are under investigation.
• Strategies to mitigate recurrence risk during MIS are being explored.
• The role of MIS in locally advanced cervical cancer remains unclear.

Conclusions:

• Minimally invasive radical hysterectomy is currently recommended only within clinical trials for cervical cancer.
• Careful patient selection and comprehensive counseling are essential.
• Further prospective studies are needed to determine the optimal surgical approach.